Ed Toland

Ed Toland is a skilled professional in the biopharmaceutical sector with extensive experience in quality control and business analysis. Currently serving as a QC Analyst II LIMS at Iovance Biotherapeutics, Inc. since February 2024, Ed has previously contributed to Teva Pharmaceuticals as a Business Process Analyst II from September 2020 to February 2024. Ed's career also includes roles at WuXi Advanced Therapies, where responsibilities included Business Analyst and Associate Business Analyst from July 2016 to September 2020, and at WuXi AppTec as Supervisor of the Central Sample Control Team and Sample Coordinator from October 2014 to July 2016. Ed holds a Bachelor of Science degree in Bioinformatics and Molecular Biology, as well as Biochemistry and Biophysics from Rensselaer Polytechnic Institute, and continued education at The University of Toledo from 2003 to 2009.